Skip to main content

Table 1 Characteristics of patients with VRE bloodstream infection

From: Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting

Characteristic

Male

50 (52%)

Age, median (years)

56 (range 20–78)

CDS-VRE score, median

1.88 (range 0–4.97)

Hematological malignancy

83 (86%)

 AML

40 (42%)

 Allogeneic stem cell transplant

26 (27%)

On antibiotics prior to BSI

91/93 (98%)

Total antibiotic days prior to BSI, median

17 (range 0–65)

Hospital admissions prior to BSI, median§

1 (range 0–10)

Transfer from another hospital

20 (21%)

Days in hospital prior to BSI, median

16 (range 0–129)

ICU admission in 30 days prior to BSI

31 (32%)

In ICU at onset of BSI

19 (20%)

Neutropenic days prior to BSI, median

11 (range 0–30)

Neutropenic at time of BSI

76 (79%)

SIRS at time of BSI

86/94 (91%)

Hypoalbuminemia days prior to BSI, median

17.5 (range 0–30)

Central venous access device

77/95 (81%)

 Tunnelled

35/95 (37%)

Indwelling urinary catheter

33/94 (35%)

Mucositis grade, median

0 (range 0–4)

  1. VRE Vancomycin resistant enterococci, CDS-VRE score Chronic Disease Score specific to VRE, AML Acute myeloid leukaemia, BSI blood stream infection, ICU Intensive care unit, SIRS Systemic inflammatory response syndrome
  2. Data not available for 2 cases
  3. Data not available for 3 cases
  4. Data not available for 1 case
  5. §12 months prior to VRE BSI